Zevia PBC (NYSE:ZVIA – Get Free Report) has been given an average recommendation of “Hold” by the six analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $4.4250.
Separately, Weiss Ratings raised shares of Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday.
Read Our Latest Report on Zevia PBC
Insiders Place Their Bets
Institutional Investors Weigh In On Zevia PBC
A number of institutional investors and hedge funds have recently made changes to their positions in ZVIA. Quadrature Capital Ltd purchased a new position in shares of Zevia PBC during the fourth quarter worth about $26,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in Zevia PBC during the 4th quarter valued at approximately $27,000. Engineers Gate Manager LP purchased a new stake in Zevia PBC during the 4th quarter valued at approximately $28,000. SG Americas Securities LLC purchased a new stake in Zevia PBC during the 4th quarter valued at approximately $31,000. Finally, JPMorgan Chase & Co. lifted its position in Zevia PBC by 2,460.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company’s stock worth $50,000 after acquiring an additional 14,912 shares during the period. 53.21% of the stock is owned by hedge funds and other institutional investors.
Zevia PBC Stock Up 1.6%
NYSE:ZVIA opened at $1.70 on Friday. The stock’s 50 day moving average price is $1.53 and its 200 day moving average price is $1.53. The company has a market capitalization of $130.64 million, a PE ratio of -16.97 and a beta of 1.00. Zevia PBC has a 52-week low of $1.11 and a 52-week high of $3.63.
Zevia PBC (NYSE:ZVIA – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). The company had revenue of $46.09 million for the quarter, compared to analyst estimates of $40.97 million. Zevia PBC had a negative return on equity of 13.43% and a negative net margin of 4.11%. As a group, sell-side analysts anticipate that Zevia PBC will post -0.1 EPS for the current fiscal year.
About Zevia PBC
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Featured Articles
- Five stocks we like better than Zevia PBC
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
